5-HT1B/1D receptor

Assets acting on this target.

Class
Triptan (5-HT1B/1D receptor agonist)

By indication

Related mechanisms

5-HT1B/1D receptor drugs compared

16 drugs, stage by indication
16 drugs acting on 5-HT1B/1D receptor: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Eletriptan (Relpax)RelpaxViatrissmall moleculeApprovedApproved in Migraine
Frovatriptan (Frova)FrovaA. Menarini, Keenova Therapeuticssmall moleculeApprovedApproved in Migraine
Meloxicam/Rizatriptan (Symbravo)SymbravoAxsome Therapeuticssmall moleculeApprovedApproved in Migraine
Naratriptan (Amerge)AmergeGlaxoSmithKlinesmall moleculeApprovedApproved in Migraine
Rizatriptan (Maxalt)MaxaltOrganonsmall moleculeApprovedApproved in Migraine
Rizatriptan (RizaFilm)RizaFilmGensco Laboratories LLCsmall moleculeApprovedApproved in Migraine
Sumatriptan (Onzetra Xsail)Onzetra XsailAzurity Pharmaceuticals, OptiNose, Inc.small moleculeApprovedApproved in Migraine
Sumatriptan (Tosymra)TosymraTonix Pharmaceuticalssmall moleculeApprovedApproved in Migraine
Sumatriptan succinate (Sumavel DosePro)Sumavel DoseProKeenova Therapeuticssmall moleculeApprovedApproved in Migraine
Sumatriptan succinate (Zembrace SymTouch)Tonix Pharmaceuticalssmall moleculeApprovedApproved in Migraine
Sumatriptan succinate injection (Imitrex)GlaxoSmithKlinesmall moleculeApprovedApproved in Migraine
Sumatriptan succinate nasal spray (Imitrex)ImitrexGlaxoSmithKlinesmall moleculeApprovedApproved in Migraine
Sumatriptan succinate tablets (Imitrex)GlaxoSmithKlinesmall moleculeApprovedApproved in Migraine
Sumatriptan/naproxen sodium (Treximet)Azurity Pharmaceuticalssmall moleculeApprovedApproved in Migraine
Almotriptan (Axert)AxertAlmirallsmall moleculeUS approval withdrawnUS approval withdrawn in Migraine
Rizatriptan/naproxenEurofarma Laboratoriossmall moleculePhase 3Phase 3 in Migraine

← all mechanisms